GLP-1 medications, specifically semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), work in part by acting on receptors in the brain that regulate hunger
Available from: eng/1389908857542/1389908896254?chap=1 Langan RC, Goodbred AJ
Use cautiously in patients with hyperthyroidism, hypertension and cardiac arrhythmias Side Effects: Transient and minor side effects of: Anxiety Tachycardia Headache Fear and palpitations occur with systemic therapeutic doses Adverse effects such as cardiac arrhythmias and excessive rise in blood pressure may also occur with therapeutic doses or inadvertent overdosage Side effects are more likely to be observed in hyperthyroid individuals Pharmacokinetics: Route of administration depends on the indication for its use : i.v., s.c., i.m., intranasal, via an endotracheal tube, or direct injection into the left ventricle
This modification enhances resistance to hyaluronidase degradation, effectively extending the residence time at the injection site
This staged method is often preferred because peptides usually dissolve more effectively in the correct initial solvent before being diluted
PlexusDx specializes in compounded peptide therapies like semaglutide and tirzepatide, plus the Precision Peptide Genetic Test to identify metabolic predispositions